Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 629.7 million
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 298.2 million
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net loss of 849,919 yuan
【财新网】国内流感疫苗龙头华兰生物疫苗股份有限公司(华兰疫苗,301207.SZ)即将上市。2月8日,华兰疫苗开始创业板新股申购,IPO拟公开发行4001万股,占发行后总股本的10%,发行价格为
图片
视频
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 629.7 million
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 298.2 million
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net loss of 849,919 yuan
热评:
【财新网】国内流感疫苗龙头华兰生物疫苗股份有限公司(华兰疫苗,301207.SZ)即将上市。2月8日,华兰疫苗开始创业板新股申购,IPO拟公开发行4001万股,占发行后总股本的10%,发行价格为
热评: